Literature DB >> 11872338

Treatment of paediatric Hodgkin's disease. a balance of risks.

A B Thomson1, W H B Wallace.   

Abstract

Hodgkin's disease is one of the commoner malignancies presenting in adolescence and young adulthood and is curable in the majority of cases. A number of therapeutic regimens have been used successfully, often at the expense of the development of side-effects in later life, including second malignancies, infertility and cardiac disease. We discuss the challenge faced by paediatric oncologists today in finding the balance between maximising cure and minimising the late effects.

Entities:  

Mesh:

Year:  2002        PMID: 11872338     DOI: 10.1016/s0959-8049(01)00335-5

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  9 in total

1.  F-18 FDG-PET imaging and correlation with CT in staging and follow-up of pediatric lymphomas.

Authors:  Miguel Hernandez-Pampaloni; Amol Takalkar; Jian Q Yu; Hongming Zhuang; Abass Alavi
Journal:  Pediatr Radiol       Date:  2006-04-19

2.  Postchemotherapy PET evaluation correlates with patient outcome in paediatric Hodgkin's disease.

Authors:  Egesta Lopci; Roberta Burnelli; Luca Guerra; Angelina Cistaro; Arnoldo Piccardo; Pietro Zucchetta; Enrico Derenzini; Alessandra Todesco; Alberto Garaventa; Fabio Schumacher; Piero Farruggia; Salvatore Buffardi; Alessandra Sala; Fiorina Casale; Paolo Indolfi; Samanta Biondi; Andrea Pession; Stefano Fanti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-05-11       Impact factor: 9.236

3.  18F-FDG PET in children with lymphomas.

Authors:  Gisele Depas; Caroline De Barsy; Guy Jerusalem; Claire Hoyoux; Marie-Françoise Dresse; Marie-France Fassotte; Nancy Paquet; Jacqueline Foidart; Pierre Rigo; Roland Hustinx
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-07-24       Impact factor: 9.236

4.  Role of PET/CT in malignant pediatric lymphoma.

Authors:  Raef Riad; Walid Omar; Magdy Kotb; Magdy Hafez; Iman Sidhom; Manal Zamzam; Iman Zaky; Hussein Abdel-Dayem
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-09-15       Impact factor: 9.236

5.  The results of Hodgkin lymphoma treatment in children in the period 1997-2006.

Authors:  Edo Hasanbegović; Snijezana Sabanović
Journal:  Bosn J Basic Med Sci       Date:  2008-02       Impact factor: 3.363

6.  Hodgkin lymphoma in childhood: clinicopathological features and therapy outcome at 2 centers from a developing country.

Authors:  Laila M Sherief; Usama R Elsafy; Elhamy R Abdelkhalek; Naglaa M Kamal; Rabab Elbehedy; Tamer H Hassan; Hanan S Sherbiny; Mohamed R Beshir; Safaa H Saleh
Journal:  Medicine (Baltimore)       Date:  2015-04       Impact factor: 1.889

Review 7.  New Insights in the Cytogenetic Practice: Karyotypic Chaos, Non-Clonal Chromosomal Alterations and Chromosomal Instability in Human Cancer and Therapy Response.

Authors:  Nelson Rangel; Maribel Forero-Castro; Milena Rondón-Lagos
Journal:  Genes (Basel)       Date:  2017-06-03       Impact factor: 4.096

8.  Can intensity of long-term follow-up for survivors of childhood and teenage cancer be determined by therapy-based risk stratification?

Authors:  A B Edgar; K Duffin; S Borthwick; P Marciniak-Stepak; W H Wallace
Journal:  BMJ Open       Date:  2013-08-02       Impact factor: 2.692

9.  Validity of reduced radiation dose for localized diffuse large B-cell lymphoma showing a good response to chemotherapy.

Authors:  Keiichiro Koiwai; Shigeru Sasaki; Eriko Yoshizawa; Hironobu Ina; Ayumu Fukazawa; Katsuya Sakai; Takesumi Ozawa; Hirohide Matsushita; Masumi Kadoya
Journal:  J Radiat Res       Date:  2013-11-01       Impact factor: 2.724

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.